Fundraising FoxTorobio
2 known investors
Find your way into Torobio
Sign up to see every warm intro you have to Torobio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Torobio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Toro Bio develops automated systems for cell and gene therapy production at point of care, enabling personalized cancer therapies. The company focuses on streamlining process development and manufacturing for therapeutic applications.
Founders & leadership
US
Umberto ScarfoglieroCo-FounderUmberto Scarfogliero has led product development for robotic systems at Amazon, BionX (acquired by Ottobock), Auris Health (acquired by Johnson & Johnson), and Rethink Robotics, with experience across FDA-regulated industries. At Torobio, he is developing automated systems for cell and gene therapy manufacturing.
Investors · 2
StartXlisted by StartXStanford · $10K – $1M
How we know: StartX's portfolio page · the VCSheet dataset · web.startx.com · Not right? Tell us
Related companies · 5
Ditto BiosciencesDitto Bio uses AI to identify protein candidates from parasites and pathogens for treating autoimmune diseases. The company mines natural compounds from viruses, ticks, and worms whose immune-modulating properties have evolved over millions of years.
BridgebioBridgeBio develops treatments for genetic conditions and cancers using a decentralized hub-and-spoke model, where autonomous teams focus on specific diseases or drug candidates while a central hub provides clinical, regulatory, and commercial support. The company partners with academic institutions to advance early-stage research toward late-stage clinical trials.
ARTBIOARTBIO develops alpha radioligand therapies (ARTs) for cancer treatment, designing target-and-molecule combinations intended to kill tumors while sparing healthy tissue. The company covers the design, manufacture, and distribution of its therapies and builds on radiation research from the University of Oslo and Norway's Radium Hospital.
Bolt BiotherapeuticsBolt Biotherapeutics is a clinical-stage biotech company developing novel immunotherapies that leverage innate immune system mechanisms to treat cancer. The company focuses on cancer immunotherapeutics and myeloid biology to address unmet patient needs.
Triana BioTRIANA Biomedicines is a venture-backed biopharmaceutical company developing small-molecule "molecular glue" therapeutics that induce protein:protein interactions to degrade or alter disease-causing target proteins, with an initial focus on targeted protein degradation for cancer. The company applies a target-first molecular glue discovery platform to pursue disease targets previously considered undruggable.
Companies working in the same space as Torobio.
Frequently asked questions
- What does Torobio do?
- Toro Bio develops automated systems for cell and gene therapy production at point of care, enabling personalized cancer therapies. The company focuses on streamlining process development and manufacturing for therapeutic applications.
- Who founded Torobio?
- Torobio was founded by Umberto Scarfogliero.
- Who are Torobio's investors?
- Torobio's investors include StartX, Taiwan Global Angels.